Recent crystal and cryo-EM structures of class B GPCRs have revealed a relatively conserved binding mode of the peptide hormones and similar orientations between the ECD and TMD when fully activated 3,4,5,8,9
Periodic reassessment of goals, side effects, and metabolic markers is essential
The most common GLP-1 side effects are gastrointestinal symptoms: nausea, vomiting, diarrhea, and constipation
Suite 110 385-472-4444 [email protected] www.hormoneclinicutah.com
Please see updated joint guidance from PCDS and ABCD, available here
Patients interested in retatrutide would need to participate in ongoing clinical trials or wait for potential FDA approval, which could take several years